United Therapeutics Corp. (UTHR)
587.50
+2.71
(+0.46%)
USD |
NASDAQ |
Oct 23, 16:00
587.82
+0.32
(+0.05%)
After-Hours: 20:00
United Therapeutics Market Cap : 25.07B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 25.07B |
| October 22, 2026 | 24.96B |
| October 21, 2026 | 24.05B |
| October 20, 2026 | 23.64B |
| October 19, 2026 | 23.18B |
| October 16, 2026 | 22.75B |
| October 15, 2026 | 23.11B |
| October 14, 2026 | 23.05B |
| October 13, 2026 | 23.19B |
| October 12, 2026 | 23.48B |
| October 09, 2026 | 23.44B |
| October 08, 2026 | 22.74B |
| October 07, 2026 | 23.26B |
| October 06, 2026 | 23.11B |
| October 05, 2026 | 22.89B |
| October 02, 2026 | 23.12B |
| October 01, 2026 | 24.38B |
| September 30, 2026 | 23.13B |
| September 29, 2026 | 20.55B |
| September 28, 2026 | 20.72B |
| September 25, 2026 | 20.29B |
| September 24, 2026 | 20.15B |
| September 23, 2026 | 20.89B |
| September 22, 2026 | 21.24B |
| September 21, 2026 | 21.04B |
| Date | Value |
|---|---|
| September 18, 2026 | 21.11B |
| September 17, 2026 | 21.22B |
| September 16, 2026 | 21.27B |
| September 15, 2026 | 21.35B |
| September 14, 2026 | 21.45B |
| September 11, 2026 | 21.22B |
| September 10, 2026 | 21.50B |
| September 09, 2026 | 21.63B |
| September 08, 2026 | 21.25B |
| September 04, 2026 | 20.81B |
| September 03, 2026 | 20.92B |
| September 02, 2026 | 21.00B |
| September 01, 2026 | 21.88B |
| August 31, 2026 | 21.78B |
| August 28, 2026 | 22.00B |
| August 27, 2026 | 22.53B |
| August 26, 2026 | 22.05B |
| August 25, 2026 | 22.13B |
| August 24, 2026 | 21.89B |
| August 21, 2026 | 21.90B |
| August 20, 2026 | 22.23B |
| August 19, 2026 | 22.58B |
| August 18, 2026 | 22.12B |
| August 17, 2026 | 21.70B |
| August 14, 2026 | 21.33B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Liquidia Corp. | 3.800B |
| MannKind Corp. | 988.62M |
| Gilead Sciences, Inc. | 193.65B |
| Insmed, Inc. | 20.39B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
Market Cap Related Metrics
| PE Ratio | 21.01 |
| PS Ratio | 8.735 |
| PEG Ratio | 2.293 |
| Price to Book Value | 3.917 |
| Price to Free Cash Flow | 25.42 |
| Price | 587.50 |
| Earnings Yield | 4.76% |
| PEGY Ratio | 2.293 |
| Operating PE Ratio | 19.63 |
| Normalized PE Ratio | 22.52 |